U.S., April 9 -- ClinicalTrials.gov registry received information related to the study (NCT06915844) titled 'Integrated HPV Vaccination and Adolescent Health in Tanzania' on March 31.
Brief Summary: Background: Cervical cancer is a serious global public health problem, particularly in sub-Saharan Africa, where it is the leading cause of cancer in women, with around 70,722 new cases each year. Vaccination against human papillomavirus (HPV) prevents cervical cancer and is usually given to children around 9 to 15 years of age. HPV vaccination has been incorporated into many countries' Expanded Programs on Immunization, but often faces optimization and uptake challenges. SHARP is an implementation research initiative in Tanzania, Nigeria, and ...